Citigroup’s Teva Call Adds to Premium: Israel Overnight

Teva Pharmaceutical Industries Ltd., the world’s largest maker of generic drugs, rallied in Tel Aviv and narrowed the widest discount to its New York-traded shares in five months as Citigroup Inc. recommended buying the stock.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.